NCT00038376 2018-10-29Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesM.D. Anderson Cancer CenterPhase 2 Completed56 enrolled
NCT00001567 2008-03-04A Phase II Efficacy Study of Roferon-A in Hairy Cell LeukemiaNational Institutes of Health Clinical Center (CC)Phase 2 Completed56 enrolled